Next Article in Journal
Increased Thoracic Fluid as the Most Distinctive Cardiovascular Hemodynamic Alteration in Men with Prolactinoma
Previous Article in Journal
Serum Low Density Lipoprotein Cholesterol Concentration Is Not Dependent on Cholesterol Synthesis and Absorption in Healthy Humans
 
 
Review
Peer-Review Record

Saffron against Neuro-Cognitive Disorders: An Overview of Its Main Bioactive Compounds, Their Metabolic Fate and Potential Mechanisms of Neurological Protection

Nutrients 2022, 14(24), 5368; https://doi.org/10.3390/nu14245368
by Débora Cerdá-Bernad 1,†, Leonor Costa 2,†, Ana Teresa Serra 2,3, Maria Rosário Bronze 2,3,4, Estefanía Valero-Cases 1, Francisca Pérez-Llamas 5, María Emilia Candela 6, Marino B. Arnao 6, Francisco Tomás Barberán 7, Rocío García Villalba 7, María-Teresa García-Conesa 7,* and María-José Frutos 1,*
Reviewer 1: Anonymous
Reviewer 2:
Nutrients 2022, 14(24), 5368; https://doi.org/10.3390/nu14245368
Submission received: 23 November 2022 / Revised: 9 December 2022 / Accepted: 14 December 2022 / Published: 17 December 2022
(This article belongs to the Section Phytochemicals and Human Health)

Round 1

Reviewer 1 Report

Dear authors,

Correct the manuscript as indicated in the text.

Comments for author File: Comments.pdf

Author Response

Uploaded as a pdf

Author Response File: Author Response.pdf

Reviewer 2 Report

I think this is a comprehensive and high quality review on the chemical composition, metabolic transformation, neuroprotective pharmacological activity and clinical progress of saffron. I agree to receive and publish it. I believe it will be helpful to the correct understanding of similar widely used natural drugs (products), but at the same time I have a little suggestions:

1.P 4,line 144,metanalyses should be meta analyses.

2.Table 2, ICR: Intestinal cancer research, should be ICR:Institute of Cancer Research.

3. Line 418 and line 414, amyloid-β peptide,the  abbreviation should be Aβ.

4.Although the main purpose of the full text is to discuss the activity, we know that any drug has both benefits and risks, because it has a relatively good activity, whether there will be some precautions or adverse reactions in drug combination, and it is suggested that it would be more reasonable and comprehensive to properly mention it in the discussion section.

Author Response

Uploaded as a pdf

Author Response File: Author Response.pdf

Back to TopTop